News and Analysis | Published:

Built-to-buy start-ups begin to bloom

Nature Reviews Drug Discovery volume 13, pages 161162 (2014) | Download Citation

A new model of company creation pioneered by Lilly, Celgene, Sanofi, Roche and others is set to deliver both clinical candidates and platform technologies.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

About this article

Publication history




  1. Search for Asher Mullard in:

Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing